Assuring The Proper Analytical Performance Of Measurement Procedures For Immunosuppressive Drug Concentrations In Clinical Practice: Recommendations Of The International Association Of Therapeutic Drug Monitoring And Clinical Toxicology Immunosuppressive Drug Scientific Committee

Monitoring immunosuppressive drugs (ISDs) in blood or plasma is still a key therapeutic drug monitoring (TDM) application in clinical settings. Narrow target ranges and severe side effects at drug underexposure or overexposure make accurate and precise measurements a must. This overview prepared by the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology is intended to serve as a summary and guidance document describing the current state-of-the-art in the TDM of ISDs.